Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with Fingolimod

Current treatment for Multiple Sclerosis (MS) consists of a multidisciplinary approach including disease-modifying therapies. The response to treatment is heterogeneous, representing a crucial challenge in the classification of patients. Metabolomics is an innovative tool that can identifies biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Murgia, Federica, Lorefice, Lorena, Noto, Antonio, Spada, Martina, Frau, Jessica, Fenu, Giuseppe, Coghe, Giancarlo, Gagliano, Antonella, Atzori, Luigi, Cocco, Eleonora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056460/
https://www.ncbi.nlm.nih.gov/pubmed/36984868
http://dx.doi.org/10.3390/metabo13030428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056460/
https://www.ncbi.nlm.nih.gov/pubmed/36984868
http://dx.doi.org/10.3390/metabo13030428

Ejemplares similares